Vaccine to treat Epstein-Brarr virus developed in mice
HQ Team August 17, 2023: A study on mice has produced a vaccine for Epstein-Barr virus, which is linked to a 32-fold higher
HQ Team August 17, 2023: Ipsen, a French drugmaker, has received FDA approval for its Sohonos capsules to treat a rare bone disorder
HQ Team August 16, 2023: Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients
HQ Team August 15, 2023: The African continent, comprising 54 sovereign nations, has āmissing, outmoded or malfunctioningā weather forecasting systems to face a
HQ Team August 15, 2023: Three people have died and 1,020 newly confirmed cases of mpox were reported globally to the WHO during
HQ Team August 15, 2023: The USFDA has granted accelerated approval for Pfizer Incās Elrexfio to treat incurable blood cancer, multiple myeloma, that
HQ Team August 14, 2023: Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes āan innovation which
HQ Team August 14, 2023: The artificial cooling of climate through geo-engineering will not work without decarbonization and involves high risks, Swiss researchers
HQ Team August 14, 2023: An intense blaze that roared through Hawaii, the largest wildfire tragedy in the US since 1918, has killed